The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
If you followed the news from the recent show of the American Association for Cancer Research (AACR), no doubt you heard about the exciting potential of liquid biopsies. These new blood-based tests,…
In a keynote talk this week for the online Genetics and Genomics conference, computational biology whiz, John Quackenbush, listed some pretty wild correlations found by a Harvard Business School stud…
Just as biomedical research is experiencing a surge of translation into clinical application, so too must the stories of this research and its impact in the lives of patients be translated to a large…
The New Republic argued in a pice entitled, "The Decline of Pseudoscience," this week that now that the so called "natural" living industry has gone mainstream, "it's days are numbered." Surely Opra…
Janitors have had a terribly busy time this week cleaning up all those jaws that were dropped on floors of research labs everywhere around the country. Have you heard about this latest sexism scandal? …
Pharma companies have always had their chief medical officers (CMOs). Now, as the diagnostics industry grows, many kinds of life science companies are filling this important position as well. Seque…
An Old New DTC Co. on the Move Let’s start with a bit of trivia. What company has resorted to selling genetic ancestry testing online direct to consumers? Hint: the company is located in the San Fr…
When President Bill Clinton stood with Francis Collins and Craig Venter in 2001 to announce the sequencing of the genome, the genome wasn’t really done.
Actually there was no news this week. It turns out the whole industry took the week off to watch the stunning Ken Burns documentary on cancer. No, that’s not true. We did find some news. How abou…
Will tech companies like Google and Apple be good at life science applications? We pursue this question today with Dale Yuzuki, the avid life science blogger, scientist, and now a marketing manager a…
The future of diagnostics is in the hands of those taking care of the biospecimen samples says, Andy Brooks our final guest in the series, Improving Biospecimen Standards. Andy is the Chief Operating…
Go about anywhere in the life science industry, and you’ll run into someone who once worked at Affymetrix. Since the founding of Affymetrix and the development of what’s come to be known simply as t…
Keira Havens is the co-founder of Revolution Bioengineering, and this week the company launched a crowd funding campaign (see video below) to produce flowers that can change colors.
Today we bring you a story which you probably wouldn’t have heard at last week’s AGBT conference at Marcos Island. While PacBio and 10X Genomics were getting most of the buzz at the annual show on a…
00:25:04 |
Tue 03 Mar 2015
Disclaimer: The podcast and artwork embedded on this page are the property of Theral Timpson. This content is not affiliated with or endorsed by eachpod.com.